Gaboxadol in Fragile X Syndrome: A 12-Week Randomized, Double-Blind, Parallel-Group, Phase 2a Study

Background: Fragile X syndrome (FXS), the most common single-gene cause of intellectual disability and autism spectrum disorder (ASD), is caused by a >200-trinucleotide repeat expansion in the 5’ untranslated region of the fragile X mental retardation 1 (FMR1) gene. Individuals with FXS can prese...

Descripción completa

Detalles Bibliográficos
Autores principales: Budimirovic, Dejan B., Dominick, Kelli C., Gabis, Lidia V., Adams, Maxwell, Adera, Mathews, Huang, Linda, Ventola, Pamela, Tartaglia, Nicole R., Berry-Kravis, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531725/
https://www.ncbi.nlm.nih.gov/pubmed/34690787
http://dx.doi.org/10.3389/fphar.2021.757825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531725/
https://www.ncbi.nlm.nih.gov/pubmed/34690787
http://dx.doi.org/10.3389/fphar.2021.757825

Ejemplares similares